Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,187 | 2,105 | 3,294 | 2,410 | 3,114 |
| Receivables | 35 | 69 | 32 | 53 | 28 |
| TOTAL | $2,081 | $3,011 | $3,429 | $2,671 | $3,367 |
| Non-Current Assets | |||||
| PPE Net | 11 | 12 | 13 | 14 | N/A |
| Other Non-Current Assets | 92 | 114 | 135 | 156 | 123 |
| TOTAL | $103 | $126 | $148 | $170 | $123 |
| Total Assets | $2,184 | $3,137 | $3,577 | $2,841 | $3,490 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 178 | 294 | 138 | 303 | 22 |
| Accrued Expenses | 127 | 85 | 77 | 76 | 139 |
| Other current liabilities | 81 | 81 | 81 | 82 | 77 |
| TOTAL | $480 | $552 | $385 | $549 | $299 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 24 | 47 | 71 | 65 |
| TOTAL | $N/A | $24 | $47 | $71 | $65 |
| Total Liabilities | $480 | $576 | $433 | $619 | $364 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,001 | 951 | 781 | 725 | 718 |
| Common Shares | 1 | 1 | 0 | 1 | 1 |
| Retained earnings | -12,454 | -11,516 | -10,324 | -9,635 | -8,311 |
| TOTAL | $1,704 | $2,561 | $3,144 | $2,222 | $3,125 |
| Total Liabilities And Equity | $2,184 | $3,137 | $3,577 | $2,841 | $3,490 |